CAH Maintained by UBS -- Price Target Raised to $295

gurufocus.com · 2026-10-16

Cardinal Health (CAH) Analyst Rating Update On October 18, 2023, UBS maintained a "Buy" rating for Cardinal Health (CAH) and raised the price target from $28

TickrTrends take: UBS raised its price target for CAH to 295, which represents analyst confidence in the company's fundamental prospects within the healthcare sector. However, TickrTrends currently derives an overvalued verdict for CAH, suggesting that the stock's current market price may already reflect or exceed the value implied by its financial metrics. Investors focused on valuation should monitor whether CAH's market performance converges with or diverges from both the analyst target and TickrTrends' assessment in the coming periods.

Read the full story at gurufocus.com →